Gene · 10397
Papers3,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Salivary Chemical Barrier Proteins in Oral Squamous Cell Carcinoma-Alterations in the Defense Mechanism of the Oral Cavity. | Int J Mol Sci | 2023 | 37686462 | PubTator, text mining | PubMed |
| Master Transcription Factor Reprogramming Unleashes Selective Translation Promoting Castration Resistance and Immune Evasion in Lethal Prostate Cancer. | Cancer Discov | 2023 | 37676710 | PubTator, text mining | PubMed |
| Complete human day 14 post-implantation embryo models from naive ES cells. | Nature | 2023 | 37673118 | PubTator, text mining | PubMed |
| Stromal-epithelial interaction induces GALNT14 in prostate carcinoma cells. | Front Oncol | 2023 | 37671061 | PubTator, text mining | PubMed |
| The Role of MicroRNAs in Development of Endometrial Cancer: A Literature Review. | J Reprod Infertil | 2023 | 37663424 | PubTator, text mining | PubMed |
| FBXW7 in breast cancer: mechanism of action and therapeutic potential. | J Exp Clin Cancer Res | 2023 | 37658431 | PubTator, text mining | PubMed |
| PROCEEDINGS OF THE XXIII CONGRESS OF THE ITALIAN ASSOCIATION OF MYOLOGY: PadovaJune 8-10, 2023. | Acta Myol | 2023 | 37650038 | PubTator, text mining | PubMed |
| Mitochondria in Cancer Stem Cells: From an Innocent Bystander to a Central Player in Therapy Resistance. | Stem Cells Cloning | 2023 | 37641714 | PubTator, text mining | PubMed |
| Research Progress and Molecular Mechanisms of Endothelial Cells Inflammation in Vascular-Related Diseases. | J Inflamm Res | 2023 | 37641702 | PubTator, text mining | PubMed |
| A Novel Nomogram for the Preoperative Prediction of Edmondson-Steiner Grade III-IV in Hepatocellular Carcinoma Patients. | J Hepatocell Carcinoma | 2023 | 37641593 | PubTator, text mining | PubMed |
| Spatially Resolved Transcriptomics Technology Facilitates Cancer Research. | Adv Sci (Weinh) | 2023 | 37632718 | PubTator, text mining | PubMed |
| Deciphering the Functional Status of Breast Cancers through the Analysis of Their Extracellular Vesicles. | Int J Mol Sci | 2023 | 37629204 | PubTator, text mining | PubMed |
| Claudin expression in pulmonary adenoid cystic carcinoma and mucoepidermoid carcinoma. | Pathol Oncol Res | 2023 | 37621953 | PubTator, text mining | PubMed |
| Potential roles of NEDD4 and NEDD4L and their utility as therapeutic targets in high‑incidence adult male cancers (Review). | Mol Clin Oncol | 2023 | 37614371 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing identifies a novel proliferation cell type affecting clinical outcome of pancreatic ductal adenocarcinoma. | Front Oncol | 2023 | 37601684 | PubTator, text mining | PubMed |
| Leveraging senescence-oxidative stress co-relation to predict prognosis and drug sensitivity in breast invasive carcinoma. | Front Endocrinol (Lausanne) | 2023 | 37600707 | PubTator, text mining | PubMed |
| Inhibition of serum- and glucocorticoid-induced kinase 1 ameliorates hydrocephalus in preclinical models. | Fluids Barriers CNS | 2023 | 37596666 | PubTator, text mining | PubMed |
| Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non-small cell lung cancer (NSCLC) through inhibition of HIF-1α. | Mol Oncol | 2023 | 37584455 | PubTator, text mining | PubMed |
| Hypoxia-driven ncRNAs in breast cancer. | Front Oncol | 2023 | 37583933 | PubTator, text mining | PubMed |
| Caffeic Acid Phenethyl Ester (CAPE) Synergistically Enhances Paclitaxel Activity in Ovarian Cancer Cells. | Molecules | 2023 | 37570782 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10397/papers?page=14